Climacteric back issues from February 2007:
Long-term trials of HRT for cardioprotection - is this as good as it gets?
Feb 01, 2007; ... Current data from randomized controlled trials (RCTs) up to 7 years long, observational studies, animal studies and laboratory studies all support the 'critical therapeutic window' hypothesis for cardioprotection when hormone replacement therapy (HRT) is initiated from near menopause1-3. In ...
Bisphosphonate-associated osteonecrosis of the jaws
Feb 01, 2007; ... Key words: BONE DISEASE, BISPHOSPHONATES, OSTEONECROSIS OF THE JAWS Bisphosphonate-associated osteonecrosis of the jaws (ONJ) was first reported in the maxillofacial surgery literature in North America1-3 and Australia in 20034. It was initially associated with intravenous ...
IMS reaction to recent breast cancer data
Feb 01, 2007; ... In the 29th San Antonio Breast Cancer Symposium, December 14-17, 2007, data from the M.D. Anderson Cancer Center at the University of Texas demonstrated an unexpected sharp decline in the incidence of breast cancer in certain areas in the United States. Overall, the incidence dropped by 8%, ...
Premature ovarian failure: a review
Feb 01, 2007; ... Key words: PREMATURE OVARIAN FAILURE, PREMATURE MENOPAUSE, HORMONE REPLACEMENT ABSTRACT Objectives To present an updated review on the etiology, consequences and management of premature ovarian failure. Design A search of the English language literature using the Cochrane ...
Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review
Feb 01, 2007; ... Key words: TIBOLONE, ANTIDEPRESSIVE AGENTS, CLONIDINE, GABAPENTIN, PHYTOESTROGENS, VERALIPRIDE, BLACK COHOSH, BREAST CANCER SURVIVORS ABSTRACT Aim This qualitative review analyzes systematically the safety of drugs used to alleviate menopausal symptoms, other than hormone ...
Relation of body mass and sex steroid hormone levels to hot flushes in a sample of mid-life women
Feb 01, 2007; ... Key words: BODY MASS INDEX, ESTROGEN, ANDROGEN, HOT FLUSHES, MENOPAUSE ABSTRACT Objective Previous studies indicate that obesity is associated with a higher risk of experiencing hot flushes in mid-life women. The reasons for this association are unknown, although altered hormone ...
Effects of acupuncture, applied relaxation, estrogens and placebo on hot flushes in postmenopausal women: an analysis of two prospective, parallel, randomized studies
Feb 01, 2007; ... Key words: VASOMOTOR SYMPTOMS, HOT FLUSHES, ACUPUNCTURE, APPLIED RELAXATION, PLACEBO ABSTRACT Objective To assess if transdermal or oral estrogens, acupuncture and applied relaxation decrease the number of menopausal hot flushes/24 h and improve climacteric symptoms, as assessed ...
Depressed mood through women's reproductive cycle: correlation to mood at menopause
Feb 01, 2007; ... Key words: MENOPAUSE, PREMENSTRUAL SYNDROME, POSTPARTUM, PREGNANCY, DEPRESSION, MOOD ABSTRACT Objectives Depressive symptoms are frequent through the different stages of a woman's reproductive cycle. The aim of this study was to evaluate a possible correlation of depressive mood ...
Menopause and post-polio symptoms as predictors of subjective sleep disturbance in poliomyelitis survivors
Feb 01, 2007; ... Key words: SLEEP, MENOPAUSE, POLIOMYELITIS, HOT FLUSHES, HORMONE REPLACEMENT THERAPY ABSTRACT Objectives Sleep disturbance in polio survivors is a common complaint, yet little is known about the effects of the interaction of physical disability and menopause on sleep. The purpose ...
The perception of menopause and hormone therapy among women in Turkey
Feb 01, 2007; ... Key words: MENOPAUSE, PERCEPTION, HORMONE THERAPY, TURKEY ABSTRACT Objectives To investigate the influence of sociodemographic characteristics and menopause perception on self-reported menopause-related symptoms among Turkish women and analyze their knowledge and attitudes ...
The experience of menopausal symptoms by Arabic women in Sydney
Feb 01, 2007; ... Key words: MENOPAUSAL SYMPTOMS, SOCIODEMOGRAPHIC, MENQOL QUESTIONNAIRE, ARABIC WOMEN, SYDNEY ABSTRACT Aim To investigate the menopausal experience of Arabic women living in Sydney and to explore the relationship between the psychosomatic symptoms and various sociodemographic ...
Letter to the Editors
Feb 01, 2007; ... Author's reply I regret that I missed the opportunity to immediately respond to Dr Parker's rebuttal1 of my invited commentary2 on the topic 'Does retention of the ovaries improve long-term survival after hysterectomy?'. Perhaps I was polite to the point of being obscure in my original ...
Angeliq® - hormone replacement therapy with drospirenone
Feb 01, 2007; ... Key words: DROSPIRENONE, PROGESTIN, HORMONE REPLACEMENT THERAPY, BLOOD PRESSURE, CARDIOVASCULAR DISEASE This Supplement combines the proceedings from a Schering AG-sponsored symposium entitled Angeliq® - hormone replacement therapy with drospirenone, held during the 12th International ...
Drospirenone and estradiol: a new option for the postmenopausal woman
Feb 01, 2007; ... Key words: HORMONE REPLACEMENT THERAPY, DROSPIRENONE, ESTROGEN, PROGESTIN, ESTRADIOL/DROSPIRENONE COMBINATION, MENOPAUSE ABSTRACT The efficacy of estrogen with or without a progestogen as hormone replacement therapy (HRT) for menopausal symptoms is well-established. Recent ...
Drospirenone and its antialdosterone properties
Feb 01, 2007; ... Key words: ALDOSTERONE, ANTIALDOSTERONE, CARDIOVASCULAR, DROSPIRENONE, PROGESTERONE, PROGESTIN ABSTRACT Drospirenone is a unique progestogen derived from 17α-spirolactone, with a pharmacologic profile very similar to that of endogenous progesterone. In contrast with other ...
Menopause and cardiovascular disease: the evidence
Feb 01, 2007; ... Key words: MENOPAUSE, CARDIOVASCULAR DISEASE, HORMONE REPLACEMENT THERAPY, DROSPIRENONE, CARDIOVASCULAR DISEASE RISK ABSTRACT Menopause is a risk factor for cardiovascular disease (CVD) because estrogen withdrawal has a detrimental effect on cardiovascular function and ...
Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women
Feb 01, 2007; ... Key words: ALDOSTERONE ANTAGONISTS, DROSPIRENONE, HORMONE THERAPY, HYPERTENSION, MENOPAUSE, PROGESTERONE, PROGESTOGENS ABSTRACT Menopause is accompanied by an increased prevalence of hypertension, which may partially explain the corresponding cardiovascular risk observed in ...
Drospirenone with 17[beta]-estradiol in the postmenopausal woman with hypertension
Feb 01, 2007; ... Key words: CARDIOVASCULAR DISEASE, HORMONE THERAPY, ESTROGEN REPLACEMENT THERAPY, MENOPAUSE, DROSPIRENONE, PROGESTOGEN ABSTRACT Hypertension is one of the most important risk factors for the development of cardiovascular disease. The prevalence of hypertension increases with age ...